Effects of R5 1163 on intake and Metabolism in Moose. Charles. C. Schwartz,'. Kris. J. Hundertmark,' and William. R. Lance2. 1 Alaska. Department of Fish and.
Journal
of Wildlife
Diseases,
27(1),
© Wildlife
Effects
of R5 1163
on intake
and Metabolism
Disease
C. Schwartz,’ Kris J. Hundertmark,’ and William R. Lance2 1 Alaska Department Moose Research Center, 34828 Kalifornsky Beach Road, Suite B, Soldotna, Alaska 99669, USA; Inc., P. 0. Box 8938, Fort Collins, Colorado 80525, USA
R51 163, a newly synthesized purine alkyl piperidine that produces reliable Sedation in cattle, was tested in five adult bull moose (Alces alces). Compared with controls, all animals dosed with 0.4 mg/kg BW ate significantly (P < 0.05) less dry matter for at least
short duration on the animal’s Five healthy
1 wk
tamed
after
treatment.
ing metabolism, did
not
differ
groups, almost
estimates
the day
between
although two times
sus control
Median
measured
moose mals
of rest-
of injection.
treatment
and
et
control
the coefficient of variation was larger for drugged (15%) verindividuals. Dose response was larger animals exhibiting longer
(8%)
allometric, with effects. Key words: R51 163, anesthesia, tranquilizer, moose, Alces alces, heat production, drymatter intake. Long-term
physiological
animals
often
necessitate
pling
of blood
the with
past, moose synthetic
which
carfentani! 1974; al.,
requires
(Franzmann
1984).
lethal
1978;
and
Gasaway
et
and
a!.,
1982;
Parker
et al., (MRC:
1984). At the Moose Alaska Department
Game,
34828
Suite
B, So!dotna,
uated
a new
tential
use
R51163 alkyl
animals
for
Alaska,
we
may
that
produces
after
purine
intravenous
(Degryse of
as a possible
wanted
a drug
sufficiently
and
this
study
tranquilizer that for
would bleeding
in-
of 0.05 (BW),
Ooms,
for
to
for yet
test
rapid
each
followed
the be
and while
15.2 were
moose.
calm
had
respi-
been a
pre-
counter-
163
on rest-
and sedation design was
given
intramuscular
lasted
s24
hr.
treatment
on
were days,
Two
and
were reversed, and the Separate trials were effects
mals
1986).
was
to
and
of R51 163; controls Intake trials lasted 14
wk
control
process was conducted
of the
drug
resting
me-
intake. standing
Animals were on a weighing
hand scale.
kicking
quently we mg/kg BW. Dry-matter
se-
and
(IM) injections at doses to 0.15 mg/kg body weight
pens
Control animals were weighed but not injected. An animal injected with 0.2 mg/ kg body weight (BW), was insufficiently tranquilized, and was capable of violent
po-
reliable
to
(Fleiss, 1986). Andivided equally into and control. Treat-
were
trials
tabolism injected
and synthesized
(Schwartz
feed intake experimental
crossover randomly treatment
bull
accustomed
All animals
injection,
to test
eval-
have
were
feeding
animals
animals repeated.
Road,
99669) that
and
effect
tractable
trained to walk onto scale for weighing. tested the effects of R51
et
moose.
purpose
R51 163
Beach
compound
in cattle
respectively
We
Kalifornsky
ration were
viously balance We
following
Center Fish and
of Fish and Game, Wildlife Laboratories,
chamber.
or
Thorne,
2
ration
(IM) injections not drugged.
Franzmann
Research of
facilities,
ment
potentially
1978;
holding
metabolism
(Haigh
1982;
is a newly
tramuscular and 0.10 The
Haigh,
piperidine
dation
are
animals
degrees
et
1991
R51 163. All aniMRC and main-
Animals
varying
In
Arneson,
Franzmann
opiates
humans
1977;
and
et al.,
Synthetic
to
immobilized etorphine
to test at the
a formulated
1985).
a two-period imals were two groups:
sam-
sedation.
been like
on ,
ing metabolism, of animals. The
of wild
repeated
have opiates
Gasaway
a!.,
studies
Association
(3-yr-old)
were used were reared
a!.
119-122
in Moose
Charles
ABSTRACT:
pp.
1991,
water ad
that
Heat production indirect respiration
of 119
was
over
of
in
conse-
tests
with
0.4
measured
a 2-wk
maintained
m pens; available
handled, our
intake
moose
were
when
conducted
daily
period. separate
Ani3.1
x
and trace mineral salt libitum. The protocol Schwartz was
measured chamber
et
al.
(1984).
using (Rege!mn
an et
JOURNAL
120
OF WILDLIFE
DISEASES,
VOL. 27, NO. 1, JANUARY
II
1991
within
I
and
sponses
among the
significance
N
was
means
were
R51
163
dry
matter
of
(Fig.
of
over
the
FIGURE
moose
1.
Daily
treated
untreated
with
intake
of dry
163 (day
HS1
control matter
of
five
1), compared
and
adult
to five
moose.
1981) following protocol described
the
Heat production was measured at 15 mm intervals in fed animals lying calmly in the respiration chamber. Statistical testing of differences between treatment and control groups abolic trials was determined for
a
2-period
1986).
crossover
Linear
covariance
TABLE 1. 2-wk period
design
regression were
used
Responses following
during by the
and
of five injection.
adult
of
H51163,
.
Weight Week
number
Treatment
1
2
1 +
2
Values ‘This These
value values
within
measured
(kg)
because
1a+b(days) Regression (b)
intake
(g/kg
individ-
were
tested
wide
variation
Elevation
(1)
Intercept
(a)
3
479
8.17”
20,13F
-4.38
4
539
6.48”
5
603
3.39’
14.24” 10.94b
-5.19 0.78
3.87
74.99
59.49
11.17
75.12 6307
9.37
1
333
3.99’
87.09’
2
372
2.33’
70.07’”
3
471
2.31’
67.75”
60.83
4
499
0.71’
36.76”
34.63
5
542
and
column
is not
significantly
different
from
the
control.
are
significantly
different
from
the
control.
with
the
4.64’
15.13”
-
1.17
83.33
-
4.48’
40.66’
-
1.52h
79.16”
same
superscripts
are
not
in
BW#{176}75/d)over
48.05’ 36.47’
All All
con-
parameters
12.29’
-
not and
metabolism
among
of the
was kg/d, and
on resting varied
food
0.8
treatment
observations
by
Slope
week ±
9#{216}3b
Drug
week
0.6
first
weight
374
All
the same
of means
the
346
Control Control
second
163
control
Mean
the
injection
sig-
of
during
significantly
different.
=
with
differed that
kg/d)
0.89):
of R51
lieu
as
=
(Ta(F
treated
injection.
0.3 kg/d for the groups, respectively.
Median
=
kg/d)
±
uals.
groups in slope 141.98).
from
0.5
±
pooled
1
Drug
1 + 2
(t
1.4
2.33)
Re-
for
2
All
Control
during
different
at beginning of week
Animal
Drug
change
Effects
variation
to
following
following
analysis
moose
(+ 1.2
week
1.8 trol
mett-test (Fleiss,
to describe
group
time
in animals
=
inlevels
period.
over treatment
±
(t
the
generally
measurement
(-3.5
intake
injection
anorexic
then
of intake
change
nificantly
recommendations by Hubbert (1987).
on
to pretreatment
pooled
Weight
0.05:
=
post
were
but
ble 1) differed significantly 15.81) and elevation (F R51163
al., and
effect 1 wk
animals intake
lines
at P
at least
2-wk
gression
re-
Statistical
±SE.
a profound for
food
trial.
determined
injection,
creased
DAY
had
animals’
intake
reported
Treated
1).
day
individual
during
1.0 70.42
7.08 67.76
a
SHORT
observed
in
ment.
some
Median
production
did
-0.072,
=
(117
P
not
differ
Resting
of
output
would
the
case
and
the
and
be
heat mean
mately sponse
extreme
and while
trough others
(50
kcal).
drugged tween trol
The
animals
though we were tion measurements evident over
to
and
This
apparent
the
approxiThis
resome
30
was
Al-
out
of
the
drug’s
partially
response
explained
observed
between
in-
dividuals. Dosage metric.
response For
450
kg;
kg.
The
allo-
was
two
two
>600
R51
studies,
weighed
largest
bull
bull
was
unable to stand BW of R51163.
when dosed He attempted
at 0.4 mg/kg to stand sev-
eral
pushing
nose
times
ground joints on
his
but
his
into
could
only
get
up on the
of his front
legs.
He
tried
hind
caused
feet
injury
secondary
and that
infection
versely, dosed
by
one at
0.4
small mg/kg
carpel of the male BW
joint was
area.
in spring
energy mortality
=
346
capable
when This
and
are
if es-
in poor
reduction
in
of D. C. Johnson
assistance
during
Morgan
This Aid
the asMc-
reviewed
study was in Wildlife
the
a contribution Restoration,
W-22-6.
LITERATURE DEGRYSE,
A. D.,
parative
A. A. OoMs.
on cardiovascular, in
of
cattle.
1986.
respiratory
the
sedatives
Drug
Comand
H 51163
Development
Re-
8: 433-441.
J. L.
1986.
experiments.
York,
432
The J.
AND of
Medicine
design Wiley
and and
analysis Sons,
New
of clinYork,
pp.
A. W.,
Immobilization
Animal
CITED
effects
xylazine
ical
L.
AND
studies
FRANZMANN,
of
for
provided statistical B. Schneider, D.
S.
manuscript. of Federal
intake
animals
help
and
E. F. Becker and K.
New
kg)
recovery during
potentially increase affect vulnerability
the
care
Knight,
in
imposed
intake could or indirectly
animal
FLEISS,
(F = 1.14), recovering during this
must be considered used on wild moose,
condition.
study. sistance,
(i.e.,
during in eleva-
level of response
reduction
pecially body
search
Con-
elevations
week.
gastrointestinal
in
and
their
significant
and
which
that
Differences observed
their upon
animals is to be
the
resulted
slopes
drugged R51 163
carpal
joints,
(BW
first The
“walking”
ultimately
greater
Project
one
of the sig-
3.97) and elcomparisons 1974) among
=
tions (F = 96.62) but not slopes indicating that all animals were at approximately the same rate
for
effect.
lines
animals differed
demonstrated
faster recovery times). the second week were
to predation. We appreciate
effects of R51 163 were time. Animals appeared
(>450 kg than small
Regression drugged dosing
elevations
exhibited
the
the
8.2%.
and
violent
differences existed between animals of different weights; smaller animals generally
for
kcal;
only
slopes
period; however, was dependent
peak
variation
exceeded
cycling
varied
ap-
unsure why heat produccycled in treated ani-
mals, it was not constant in
at to trough);
(>100 kcal), slight variation of
of variation
cycle
high
was 15%. Variation below measurements in con-
seldom
coefficient
very
between
coefficient
animals high and
was
Treated
values. individuals;
measurements showed only
BW).
of
were
variation
kg
uptake
readings
to control among
(